cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Ac Immune Sa
46 own
32 watching
Current Price
$2.42
$0.05
(2.11%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
202.02M
52-Week High
52-Week High
4.84
52-Week Low
52-Week Low
1.68
Average Volume
Average Volume
0.03M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
9.8528
iconMarket Capitalization202.02M
icon52-Week High4.84
icon52-Week Low1.68
iconAverage Volume0.03M
iconDividend Yield--
iconP/E Ratio9.8528
What does the Ac Immune Sa do?
AC Immune SA is a biopharmaceutical company. It is engaged in leveraging its two proprietary technology platforms to discover, design and develop novel, proprietary medicines for treatment of neurodegenerative diseases.
Read More
News & Events about Ac Immune Sa.
Globe Newswire
6days ago
AC Immune to Present at the SVB Securities Global Biopharma Conference Lausanne, Switzerland, February 2, 2023 AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will ...
Globe Newswire
2 months ago
Next generation SupraAntigen liposomal vaccine platform augments immunization against pathological targets of Alzheimers diseaseNew data on anti-phospho-Tau vaccines confirm safety, tolerability and immunogenicity of ACI-35 and JACI-35, developed in collaboration with Janssen ...
Globe Newswire
3 months ago
LAUSANNE, Switzerland, Nov. 08, 2022 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that company management will participate in a fireside chat and one-on-one investor meetings ...
Globe Newswire
3 months ago
Announced initiation of dosing of anti-Abeta vaccine ACI-24.060 in the biomarker-based Phase 1b/2 ABATE study in patients with prodromal Alzheimers disease and individuals with Down syndromeReceived regulatory clearance to initiate an adaptive, biomarker-based Phase 2 study of the anti-alpha-...
Frequently Asked Questions
Frequently Asked Questions
What is Ac Immune Sa share price today?
plus_minus_icon
Can Indians buy Ac Immune Sa shares?
plus_minus_icon
How can I buy Ac Immune Sa shares from India?
plus_minus_icon
Can Fractional shares of Ac Immune Sa be purchased?
plus_minus_icon
What are the documents required to start investing in Ac Immune Sa stocks?
plus_minus_icon
What is today’s traded volume of Ac Immune Sa?
plus_minus_icon
What is today’s market capitalisation of Ac Immune Sa?
plus_minus_icon
What is the 52-Week High and Low Range of Ac Immune Sa?
plus_minus_icon
What percentage is Ac Immune Sa down from its 52-Week High?
plus_minus_icon
What percentage is Ac Immune Sa up from its 52-Week Low?
plus_minus_icon
Current Price
$2.42
$0.05
(2.11%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00